BACKGROUND AND OBJECTIVES: Electronic personal health records (PHRs) allow patients access to their medical records, self-management tools, and new avenues of communication with their health care providers.
FDA issues guidance on antioxidants. The US Food and Drug Administration (FDA) has published guidance to help small companies comply with the labeling of antioxidant products and high potency products. The Small Entity Compliance Guide sets out the agencyâs position âin plain languageâ regarding the use of the nutrient content claims on dietary supplement products.
Butylated hydroxyanisole â also known as BHA â is an antioxidant primarily used as a preservative in food, animal feed, cosmetics, rubber and petroleum products. The National Toxicology Program of the Department of Health and Human Services warns that BHA is âreasonably anticipated to be a human carcinogenâ (cancer-causing agent).